Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

207
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
207
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

182
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
182
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

711
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
711
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

607
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
607
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

636
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
636
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

335
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
335

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcript-independent quantitative analysis of RNA cap structures by LC-MS/MS.

Molecular therapy. Advances·2026
Same author

Conventional Cardiac Surgery in Donation After Circulatory Death Heart Transplantation: A United Network for Organ Sharing Registry Analysis.

Clinical transplantation·2026
Same author

Effects of Functional Warm Ischemia Time on Posttransplant Outcomes in Donation After Circulatory Death Heart Transplantation Using Direct Procurement and Perfusion.

Transplantation·2026
Same author

Semi-Empirical Model to Predict Blood Flow in an Extracorporeal Respiratory Support Circuit Driven by Ventricular Assist Devices.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Association of posttransplant dialysis and survival after donation after circulatory death heart transplantation.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Robotically-Assisted Resection of Leiomyomatosis in the Inferior Vena Cava With Right Atrial and Ventricular Extension.

The American journal of cardiology·2026

Related Experiment Video

Updated: Oct 19, 2025

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.7K

Doxycycline-Induced Gastric Perforation.

Yeahwa Hong1, Christopher Staniorski2, Dean Pollack3

  • 1Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

The American Surgeon
|September 23, 2021
PubMed
Summary

Doxycycline can cause esophageal and gastric injuries. This report details the first known case of gastric perforation resulting from doxycycline use, highlighting a rare but severe complication.

Keywords:
doxycyclinegastric perforationmedication adverse effect

More Related Videos

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

540
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K

Related Experiment Videos

Last Updated: Oct 19, 2025

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.7K
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

540
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Clinical Medicine

Background:

  • Doxycycline is a common antibiotic with known gastrointestinal side effects.
  • Esophageal and gastric mucosal injuries are documented adverse effects, presenting as odynophagia, chest pain, and abdominal pain.
  • Diagnostic criteria for these injuries are not well-established, relying heavily on patient history.

Observation:

  • A case of gastric perforation following doxycycline use is presented.
  • This represents a rare and potentially life-threatening complication of doxycycline-induced mucosal injury.
  • Literature on severe complications like hemorrhage and perforation from doxycycline is scarce.

Findings:

  • The study reports the first documented instance of gastric perforation linked to doxycycline administration.
  • This finding underscores the potential for severe gastrointestinal damage from this antibiotic.
  • The case highlights the importance of considering doxycycline as a causative agent in severe upper gastrointestinal events.

Implications:

  • Clinicians should be aware of the possibility of gastric perforation as a rare complication of doxycycline.
  • Further research may be needed to elucidate the mechanisms and risk factors for severe doxycycline-induced mucosal injury.
  • This case emphasizes the need for careful patient history and consideration of medication side effects in diagnosing gastrointestinal issues.